GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nippon Shinyaku Co Ltd (TSE:4516) » Definitions » Debt-to-Equity

Nippon Shinyaku Co (TSE:4516) Debt-to-Equity : 0.01 (As of Dec. 2023)


View and export this data going back to 1962. Start your Free Trial

What is Nippon Shinyaku Co Debt-to-Equity?

Nippon Shinyaku Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円1,297 Mil. Nippon Shinyaku Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円751 Mil. Nippon Shinyaku Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was 円215,007 Mil. Nippon Shinyaku Co's debt to equity for the quarter that ended in Dec. 2023 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Nippon Shinyaku Co's Debt-to-Equity or its related term are showing as below:

TSE:4516' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.01   Max: 0.02
Current: 0.01

During the past 13 years, the highest Debt-to-Equity Ratio of Nippon Shinyaku Co was 0.02. The lowest was 0.01. And the median was 0.01.

TSE:4516's Debt-to-Equity is ranked better than
99.88% of 854 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs TSE:4516: 0.01

Nippon Shinyaku Co Debt-to-Equity Historical Data

The historical data trend for Nippon Shinyaku Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nippon Shinyaku Co Debt-to-Equity Chart

Nippon Shinyaku Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.02 0.02 0.02 0.01

Nippon Shinyaku Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Competitive Comparison of Nippon Shinyaku Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Shinyaku Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nippon Shinyaku Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nippon Shinyaku Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Nippon Shinyaku Co's Debt-to-Equity falls into.



Nippon Shinyaku Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Nippon Shinyaku Co's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Nippon Shinyaku Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nippon Shinyaku Co  (TSE:4516) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Nippon Shinyaku Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Nippon Shinyaku Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Nippon Shinyaku Co (TSE:4516) Business Description

Traded in Other Exchanges
Address
14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, JPN, 601-8550
Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Nippon Shinyaku Co (TSE:4516) Headlines

No Headlines